AMYLYX
Live / Registered — Registered (as of 05 May 2020)
What this means for you
Registered since 05 May 2020. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (the §8 declaration of use was due 05 May 2026; it can still be filed, with a surcharge, until 05 Nov 2026).
Record
- Serial number
- 88319631
- Registration number
- 6048913
- Mark type
- Word mark
- Filed
- 28 Feb 2019
- Published for opposition
- 25 Jun 2019
- Registered
- 05 May 2020
- Next maintenance filing
- §8 declaration of use, due by 05 May 2026 (grace period to 05 Nov 2026)
- Attorney of record
- Cynthia Johnson Walden
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of neurological diseases and neurodegenerative diseases
Owner
- Amylyx Pharmaceuticals, Inc., Cambridge, MA, US
- Amylyx Pharmaceuticals, Inc., Cambridge, MA, US
- Amylyx Pharmaceuticals, Inc., Cambridge, MA, US
Board proceedings on this mark
The owner also pleads this mark in 1 other Board proceeding.
Prosecution history
- 23 Feb 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 23 Feb 2026 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 23 Feb 2026 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 23 Feb 2026 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 23 Feb 2026 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 05 May 2025 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 05 May 2020 — REGISTERED-PRINCIPAL REGISTER
- 02 Apr 2020 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 01 Apr 2020 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 10 Mar 2020 — STATEMENT OF USE PROCESSING COMPLETE
- 19 Feb 2020 — USE AMENDMENT FILED
- 09 Mar 2020 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 19 Feb 2020 — TEAS STATEMENT OF USE RECEIVED
- 19 Feb 2020 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 19 Feb 2020 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED